Gossamer Bio, Inc. (GOSS) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 708.41M |
| Enterprise Value | 873.58M |
| P/E Ratio | -0.27 |
| PEG Ratio | 0.14 |
| Price/Sales Ratio | 1.42 |
| Price/Book Ratio | -0.53 |
| Enterprise/Revenue | 1.38 |
| Enterprise/EBITDA | -0.36 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -2.35 |
| Operating Margin | -3.12 |
| Return On Assets | -1.63 |
| Return On Equity | 1.09 |
| Revenue | 48.47M |
| Revenue/Share | 0.17 |
| Gross Profit | 47.47M |
| EBITDA | -158.47M |
| Net Income | -170.37M |
| Diluted EPS | -0.75 |
| Total Cash | 57.03M |
| Total Cash/Share | 0.18 |
| Total Debt | 39.1M |
| Total Debt/Equity | -0.42 |
| Current Ratio | 0.53 |
| Book Value Per Share | -0.29 |
| 52-Week Change | -93.39 |
| 52-Week High | 3.87 |
| 52-Week Low | 0.11 |
| Moving Average 50 Days | 0.17 |
| Moving Average 200 Days | 1.22 |
| Average Volume | 27M |
| Shares Outstanding | 488.85M |
| % Held by Institutions | 71.34 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |